Favorable Recovery Rates for Adolescent Eating Disorders
One in five patients with adolescent-onset anorexia nervosa have a chronic eating disorder 30 years later.
Anorexia Nervosa
Oral Contraceptives Offer Some Protection Against Bone Loss in Anorexia Nervosa
For young women with anorexia nervosa, oral contraceptives may limit bone loss.
Bone Health in Adolescents With Anorexia Nervosa and Atypical Anorexia Nervosa
Adolescents with atypical anorexia nervosa have higher bone mass density on average than adolescents with anorexia nervosa, but still experience significant deficits in fat mass index.
Olanzapine Shows Modest Benefit for Weight Gain in Anorexia Nervosa
Investigators sought to determine whether olanzapine promotes weight gain and improves psychological symptoms in patients with anorexia nervosa.
Eating Disorder Prevalence in Children Age 9 to 10 Shows No Sex-Based Differences
No significant sex differences were found in the prevalence of eating disorders in children age 9 to 10.
Prediction Error and Altered Dopamine Function May Play Key Role in Anorexia Nervosa
The altered brain reward response seen in adolescents with anorexia in this study may indicate alterations in dopamine function, which may play a key role in anorexia’s pathophysiology.
Effects of the 2 Types of Anorexia Nervosa on Bone Metabolism
Investigators sought to determine whether both restrictive and purging types of anorexia nervosa effect bone metabolism.
Fracture Type Varies for Women With Anorexia and Oligo-Amenorrheic Athletes
Women with anorexia nervosa and oligo-amenorrheic athletes have been reported to have low bone mineral density and an increased fracture risk.
Unfavorable Outcomes Common in Childhood Anorexia Nervosa
Adolescents who develop anorexia nervosa before the age of 14 have a higher risk of unfavorable outcomes.
Ghrelin Agonist Decreased Gastric Emptying Time in Women With Anorexia
As there are no currently approved medical therapies for the treatment of anorexia, further study is necessary to determine the long-term efficacy and safety of a ghrelin agonist.
